Modern Collapse Therapy for Pulmonary Tuberculosis - 19/11/18
, Sergey V. Skluev, PhD c, d, Yana K. Petrova, PhD a, Dmitry A. Skvortsov, PhD a, Vladimir A. Krasnov, MD, PhD b, e, Irina G. Felker, PhD c, Nikolay Grischenko, MD, PhD aRésumé |
Multidrug-resistant tuberculosis (TB), extensively drug-resistant TB, and TB–human immunodeficiency virus (HIV) coinfection require a special approach in anti-TB treatment. Most patients cannot be successfully cured by conventional chemotherapy alone. They need a modern approach using minimally invasive therapeutic and surgical techniques. The novel approaches of collapse therapy techniques and minimally invasive osteoplastic thoracoplasty increase the effectiveness of complex anti-TB therapy. Achieving the required selective collapse of lung tissue in destructive pulmonary TB, especially in cases of drug resistance and/or HIV coinfection, leads to bacteriologic conversion, cavity closure, and successful cure.
Le texte complet de cet article est disponible en PDF.Keywords : Collapse therapy, Pulmonary tuberculosis, TB-HIV coinfection, Endobronchial valve, Thoracoplasty
Plan
| Disclosure Statement for Conflicts of Interest: Authors of this publication certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated. Authors of this publication certify that all financial and material support for this research and work are clearly identified in the title page of the article. One of the studies reported in this publication (Endobronchial valve application in patients with TB-HIV coinfection) was supported by the grant of the President of the Russian Federation MD-7123.2015.7. |
Vol 29 - N° 1
P. 47-58 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
